







Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques...
We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
The global Chinese Medicine Herb market has undergone a seismic shift from traditional "raw herb decoctions" to highly concentrated TCM Granules. As of 2024, the market size for botanical extracts and herbal medicines has surpassed $150 billion, driven by a growing preference for natural therapies in North America, Europe, and Southeast Asia. The industrial trend is moving toward "Scientific TCM," where standardization, traceability, and quantifiable efficacy are non-negotiable requirements for international buyers.
Modern pharmaceutical buyers and wellness brands are no longer just looking for "suppliers"; they are looking for "supply chain partners." Today's procurement focus includes:
Our Formula Herb Capsules are designed to meet these modern convenience needs without sacrificing therapeutic potency.
The integration of AI in herb authentication and the use of big data in "precision TCM" are the next frontiers. As a leading exporter, Neo-Green Herbs utilizes patented extraction technologies that preserve the "Full Spectrum" of the herbs, ensuring that our TCM granules are as close to nature as possible while being biologically enhanced for faster absorption.
The versatility of TCM granules allows them to fit seamlessly into various global healthcare models:
By using concentrated TCM granules, pharmacists can dispense formulas up to 10 times faster than traditional raw herb weighing. For example, our Linking Formula provides a stable, laboratory-tested profile that ensures Every dose is identical in strength, a critical factor for clinical efficacy and patient trust.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation.
As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
Our production advantage lies in our "Seed-to-Sachet" vertical integration. We control over 10,000 acres of GAP-certified (Good Agricultural Practices) herb cultivation bases. This allows us to ensure that the Chinese Medicine Herb raw materials are harvested at their peak potency. Our factory utilizes low-temperature digital extraction, which prevents the degradation of volatile essential oils—a common flaw in third-party manufacturing.
Navigating the complex regulatory landscape of international herb trade is our forte. As a premier TCM granules exporter, we provide full documentation support including Certificates of Analysis (CoA), MSDA, and specific regulatory filings for different regions. Our logistics network facilitates temperature-controlled shipping to preserve the shelf life and efficacy of our herbal extracts from China to any corner of the world.
Whether you are a large medical institution or a boutique herbal pharmacy, our flexible B2B order fulfillment ensures you have the inventory you need, when you need it. We specialize in bulk supply and wholesale distribution, offering competitive pricing due to our direct factory-to-market model.







